<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02477644</url>
  </required_header>
  <id_info>
    <org_study_id>GINECO-OV125b</org_study_id>
    <nct_id>NCT02477644</nct_id>
  </id_info>
  <brief_title>Platine, Avastin and OLAparib in 1st Line</brief_title>
  <acronym>PAOLA-1</acronym>
  <official_title>Randomized, Double-Blind, Phase III Trial Olaparib vs. Placebo Patients With Advanced FIGO Stage IIIB-IV High Grade Serious or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer Treated Standard First-Line Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ARCAGY/ GINECO GROUP</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arbeitsgemeinschaft Gynaekologishe Onkologie Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arbeitsgemeinschaft Gynaekologische Onkologie Austria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Grupo Español de Investigación en Cáncer de Ovario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Belgian Gynaecological Oncology Group</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mario Negri Gynecologic Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nordic Society for Gynaecologic Oncology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gynecologic Oncology Trial &amp; Investigation Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ARCAGY/ GINECO GROUP</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, Double-Blind, Phase III Trial of Olaparib vs. Placebo in Patients with Advanced
      FIGO Stage IIIB - IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal
      Cancer treated with standard First-Line Treatment, Combining Platinum-Taxane Chemotherapy and
      Bevacizumab Concurrent with Chemotherapy and in Maintenance.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with advanced FIGO stage IIIB - IV high grade serous or endometrioid ovarian,
      fallopian tube, or peritoneal cancer treated with standard first-line treatment, combining
      platinum-taxane chemotherapy and bevacizumab concurrent with chemotherapy and in maintenance.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy by progression free survival (PFS1)</measure>
    <time_frame>phase up to a total of 15 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>Study end</time_frame>
    <description>Overall survival is defined as the time from the date of randomization until death due to any cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to earliest progression by RECIST or CA-125</measure>
    <time_frame>Study end</time_frame>
    <description>Time to earliest progression by RECIST v. 1.1 or CA-125 or death is defined as the time from randomization to the earliest date of RECIST or CA-125 progression or death by any cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Second Progression Free Survival (PFS2)</measure>
    <time_frame>Study end</time_frame>
    <description>Time from randomization to second progression is defined as the time from the date of randomization to the earliest of the progression event subsequent to that used for the primary variable PFS, or date of death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to start of first subsequent therapy or death (TFST)</measure>
    <time_frame>Study end</time_frame>
    <description>Time to start of first subsequent therapy or death (TFST) will be assessed. TFST is defined as the time from the date of randomization to the earliest of the date of anti-cancer therapy start date following study treatment discontinuation, or death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to start of second subsequent therapy or death (TSST)</measure>
    <time_frame>Study end</time_frame>
    <description>Time to start of second subsequent therapy or death (TSST) will be assessed. TSST is defined as the time from the date of randomization to the earliest of the date of second subsequent anti-cancer therapy start date following study treatment discontinuation, or death.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and Tolerability</measure>
    <time_frame>Study end</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcome</measure>
    <time_frame>2 years after last patient included</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">612</enrollment>
  <condition>Ovarian Cancer</condition>
  <arm_group>
    <arm_group_label>Olaparib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tablets per os 300 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tablets per os 300 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Olaparib</intervention_name>
    <description>Tablets, per os, 300 mg twice daily;</description>
    <arm_group_label>Olaparib</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Tablets, per os, 300 mg twice daily.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        I-1. Female Patient must be ≥18 years of age. I-2. Signed informed consent and ability to
        comply with treatment and follow-up.

        I-3. Patient with newly diagnosed I-3-1 Ovarian cancer, primary peritoneal cancer and/or
        fallopian-tube cancer,

        I-3-2 Histologically confirmed (based on local histopathological findings):

          -  high grade serous or

          -  high grade endometrioid or

          -  other epithelial non mucinous ovarian cancer in a patient with germline BRCA 1 or 2
             deleterious mutation I-3-3 at an advanced stage: FIGO stage IIIB, IIIC, or IV of the
             1988 FIGO classification.

        I-4. Patient who has completed prior to randomization first line platinum-taxane
        chemotherapy:

          1. Platinum-taxane based regimen must have consisted of a minimum of 6 treatment cycles
             and a maximum of 9. However if platinum based therapy must be discontinued early as a
             result of non hematological toxicity specifically related to the platinum regimen,
             (i.e. neurotoxicity, hypersensitivity etc.), patient must have received a minimum of 4
             cycles of the platinum regimen.

          2. Intravenous, intraperitoneal, or neoadjuvant platinum based chemotherapy is allowed;
             for weekly therapy, three weeks are considered one cycle. Interval debulking is
             allowed.

        I-5. Patient must have received prior to randomization a minimum of 3 cycles of bevacizumab
        in combination with the 3 last cycles of platinum-based chemotherapy. Only in case of
        interval debulking surgery, it is allowed to realize only 2 cycles of bevacizumab in
        combination with the last 3 cycles of platinium-based chemotherapy. Bevacizumab treatment
        should be administered at a dose 15mg/kg q3 weeks up to a total of 15 months.

        I-6. Patient must be prior to randomization without evidence of disease (NED) or in
        complete response (CR) or partial response (PR) from her first line treatment. There should
        be no clinical evidence of disease progression (physical exam, imagery, CA 125) throughout
        her first line treatment and prior to study randomization.

        I-7. Patient must be randomized at least 3 weeks and no more than 9 weeks after her last
        dose of chemotherapy (last dose is the day of the last infusion) and all major toxicities
        from the previous chemotherapy must have resolved to CTC AE grade 1 or better (except
        alopecia and peripheral neuropathy).

        I-8. Patient must have normal organ and bone marrow function:

          1. Hemoglobin ≥ 10.0 g/dL.

          2. Absolute neutrophil count (ANC) ≥ 1.5 x 109/L.

          3. Platelet count ≥ 100 x 109/L.

          4. Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN).

          5. Aspartate aminotransferase /Serum Glutamic Oxaloacetic Transaminase (ASAT/SGOT)) and
             Alanine aminotransferase /Serum Glutamic Pyruvate Transaminase (ALAT/SGPT)) ≤ 2.5 x
             ULN, unless liver metastases are present in which case they must be ≤ 5 x ULN.

          6. Serum creatinine ≤ 1.25 x institutional ULN and creatinine clearance &gt; 50 mL/min.

          7. Patient not receiving anticoagulant medication who has an International Normalized
             Ratio (INR) ≤1.5 and an Activated ProThrombin Time (aPTT) ≤1.5 x ULN.

             The use of full-dose oral or parenteral anticoagulants is permitted as long as the INR
             or APTT is within therapeutic limits (according to site medical standard). If the
             patient is on oral anticoagulants, dose has to be stable for at least two weeks at the
             time of randomization.

          8. Urine dipstick for proteinuria &lt; 2+. If urine dipstick i s ≥2+, 24-hour urine must
             demonstrate &lt;1 g of protein in 24 hours.

          9. Normal blood pressure or adequately treated and controlled hypertension (systolic BP ≤
             140 mmHg and/or diastolic BP ≤ 90 mmHg).

        I-9. Eastern Cooperative Oncology Group (ECOG) performance status 0-1. I-10. Formalin
        fixed, paraffin embedded (FFPE) tumor sample from the primary cancer must be available for
        central BRCA testing and test result must be available for stratification.

        I-11. Postmenopausal or evidence of non-childbearing status for women of childbearing
        potential prior to the first dose of study treatment. (see appendix 4) I-12. For France
        only: In France, a subject will be eligible for randomization in this study only if either
        affiliated to, or a beneficiary of, a social security category.

        Exclusion Criteria:

        E-1. Non-epithelial origin of the ovary, the fallopian tube or the peritoneum (i.e. germ
        cell tumors).

        E-2. Ovarian tumors of low malignant potential (e.g. borderline tumors), or mucinous
        carcinoma.

        E-3. Patient with synchronous primary endometrial cancer unless both of the following
        criteria are met:

          1. stage &lt; II,

          2. Less than 60 years old at the time of diagnosis of endometrial cancer with stage IA or
             IB grade 1 or 2, or stage IA grade III endometrioid adenocarcinoma OR ≥ 60 years old
             at the time of diagnosis of endometrial cancer with stage IA grade 1 or 2 endometrioid
             adenocarcinoma.

        Patient with serous or clear cell adenocarcinoma or carcinosarcoma of the endometrium is
        not eligible.

        E-4. Other malignancy within the last 5 years except: adequately treated non-melanoma skin
        cancer curatively treated in situ cancer of the cervix, ductal carcinoma in situ (DCIS).
        Patient with a history of localized malignancy diagnosed over 5 years ago may be eligible
        provided she completed her adjuvant systemic therapy prior to randomization and that the
        patient remains free of recurrent or metastatic disease.

        Patient with history of primary triple negative breast cancer may be eligible provided she
        completed her definitive anticancer treatment more than 3 years ago and she remains breast
        cancer disease free prior to start of study treatment.

        E-5. Patient with myelodysplastic syndrome/acute myeloid leukemia history E-6. Patient
        having experienced for at least one cycle, a delay &gt; 2 weeks due to prolonged hematological
        recovery during the first line chemotherapy E-7. Patient receiving radiotherapy within 6
        weeks prior to study treatment E-8. Major surgery within 4 weeks of starting study
        treatment and patient must have recovered from any effects of any major surgery E-9.
        Previous allergenic bone marrow transplant. E-10. Any previous treatment with PARP
        inhibitor, including olaparib. E-11. Administration of other simultaneous chemotherapy
        drugs, any other anticancer therapy or anti-neoplastic hormonal therapy, or simultaneous
        radiotherapy during the trial treatment period (hormonal replacement therapy is permitted
        as are steroidal antiemetics).

        E-12. Current or recent (within 10 days prior to randomization) chronic use of aspirin &gt;
        325 mg/day.

        E-13. Concomitant use of known potent CYP3A4 inhibitors such as ketoconazole, itraconazole,
        ritonavir, indinavir, saquinavir, telithromycin, clarithromycin and nelfinavir.

        E-14. Prior history of hypertensive crisis (CTC-AE grade 4) or hypertensive encephalopathy.

        E-15. Clinically significant (e.g. active) cardiovascular disease, including:

          1. Myocardial infarction or unstable angina within ≤ 6 months of randomization,

          2. New York Heart Association (NYHA) ≥ grade 2congestive heart failure (CHF).

          3. Poorly controlled cardiac arrhythmia despite medication (patient with rate controlled
             atrial fibrillation are eligible), or any clinically significant abnormal finding on
             resting ECG,

          4. Peripheral vascular disease grade ≥ 3 (e.g. symptomatic and interfering with
             activities of daily living [ADL] requiring repair or revision).

        E-16. Previous Cerebro-Vascular Accident (CVA), Transient Ischemic Attack (TIA) or Sub-
        Arachnoids Hemorrhage (SAH) within 6 months prior to randomization.

        E-17. History or evidence of hemorrhagic disorders within 6 months prior to randomization.

        E-18. Evidence of bleeding diathesis or significant coagulopathy (in the absence of
        coagulation).

        E-19. History or clinical suspicion of brain metastases or spinal cord compression. CT/MRI
        of the brain is mandatory (within 4 weeks prior to randomization) in case of suspected
        brain metastases. Spinal MRI is mandatory (within 4 weeks prior to randomization) in case
        of suspected spinal cord compression.

        E-20. History or evidence upon neurological examination of central nervous system (CNS)
        disease, unless adequately treated with standard medical therapy (e.g. uncontrolled
        seizures).

        E-21. Significant traumatic injury during 4 weeks prior to randomization. E-22. Non-healing
        wound, active ulcer or bone fracture. Patient with granulating incisions healing by
        secondary intention with no evidence of facial dehiscence or infection is eligible but
        require 3 weekly wound examinations.

        E-23. History of VEGF therapy related abdominal fistula or gastrointestinal perforation or
        active gastrointestinal bleeding within 6 months prior to the first study treatment.

        E-24. Current, clinically relevant bowel obstruction, including sub-occlusive disease,
        related to underlying disease.

        E-25. Patient with evidence of abdominal free air not explained by paracentesis or recent
        surgical procedure.

        E-26. Evidence of any other disease, metabolic dysfunction, physical examination finding or
        laboratory finding giving reasonable suspicion of a disease or condition that
        contraindicates the use of an investigational drug or puts the patient at high risk for
        treatment related complications.

        E-27. Pregnant or lactating women. E-28. Participation in another clinical study with an
        investigational product during her chemotherapy course immediately prior to randomization.

        E-29. Patient unable to swallow orally administered medication and patient with
        gastrointestinal disorders likely to interfere with absorption of the study medication.

        E-30. Patient with a known hypersensitivity to olaparib or any of the recipients of the
        product.

        E-31. Immunocompromised patient, e.g., with known active hepatitis (i.e. Hepatitis B or C)
        due to risk of transmitting the infection through blood or other body fluids or patient who
        is known to be serologically positive for human immunodeficiency virus (HIV).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle RAY COQUARD, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Leon Berard</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sylvie MIJONNET</last_name>
    <phone>+ 33 (0)1 42 34 83 23</phone>
    <email>smijonnet@arcagy.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hubert PANIEZ</last_name>
    <phone>+ 33 (0)1 42 34 83 23</phone>
    <email>hpaniez@arcagy.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KH der Barmherzigen Brüder Graz</name>
      <address>
        <city>Graz</city>
        <zip>8020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Schauer, MD</last_name>
      <phone>+43 316 7067 6653</phone>
      <email>Christian.schauer@bbgraz.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Graz</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edgar Petru, MD</last_name>
      <phone>+43 316 385 81 0 82</phone>
      <email>edgar.petru@medunigraz.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Marth, MD, PhD</last_name>
      <phone>+43 512 504 23050</phone>
      <email>Christian.marth@tirol-kliniken.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus Salzburg</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerhard Bogner, MD</last_name>
      <phone>+43 662 4482</phone>
      <email>g.bogner@salk.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Reinthaller, MD, PhD</last_name>
      <phone>+43 1 40400 29110</phone>
      <email>Alexander.reinthaller@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Hietzing</name>
      <address>
        <city>Vienna</city>
        <zip>1130</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Sevelda, MD, PhD</last_name>
      <phone>+43 1 80110 2294</phone>
      <email>Paul.sevelda@wienkav.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Jules Bordet</name>
      <address>
        <city>Bruxelles</city>
        <zip>B1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joseph KERGER, MD</last_name>
      <phone>32 2 541 7396</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Antwerp University Hospital</name>
      <address>
        <city>Edegem</city>
        <zip>B-2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Manon T Huizing, MD</last_name>
      <phone>32 3 821 32 50</phone>
      <email>borstkliniek@uza.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>B - 3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignace VERGOTE, MD</last_name>
      <phone>32 16 33 22 11</phone>
      <email>ignace.vergote@uzleuven.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Citadelle</name>
      <address>
        <city>Liège</city>
        <zip>B-4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Frederic GOFFIN, MD</last_name>
      <phone>32 4 225 67 62</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique et maternité Sainte Elisabeth</name>
      <address>
        <city>Namur</city>
        <zip>B-5000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter VUYLSTEKE, MD</last_name>
      <phone>32 81 72 05 47</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Dinant Godinne</name>
      <address>
        <city>Yvoir</city>
        <zip>B-5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lionel D'HONDT, MD</last_name>
      <phone>32 81 42 38 58</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mansoor RAZA MIRZA, MD</last_name>
      <phone>004535459624</phone>
      <email>Mansoor.Raza.Mirza@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Herlev</city>
        <zip>2720</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Trine Juhler-Nøttrup, MD</last_name>
      <phone>+45 3868 2873</phone>
      <email>trine.juhler-noettrup@regionh.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kuopio University Hospital</name>
      <address>
        <city>Kuopio</city>
        <zip>70210</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maarit ANTTILA, MD</last_name>
      <phone>+ 358 44 7174617</phone>
      <email>maarit.antila@kuh.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <zip>FIN-90029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ulla PUISTOLA, MD</last_name>
      <phone>+358 8 3152011</phone>
      <email>ulla.puistola@oulu.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>FI-33521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Johanna MÄENPÄÄ, MD</last_name>
      <phone>+358-3-3116 5046</phone>
      <email>johanna.maenpaa@staff.uta.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sakari HIETANEN, MD</last_name>
      <email>sakari.hietanen@tyks.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICO Paul Papin</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie ABADIE-LACOURTOISIE, MD</last_name>
      <phone>2 41 35 27 00</phone>
      <phone_ext>0033</phone_ext>
      <email>sophie.abadie-lacourtoisie@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Sainte-Catherine</name>
      <address>
        <city>Avignon</city>
        <zip>84918</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien GRENIER, MD</last_name>
      <phone>4 90 27 63 97</phone>
      <phone_ext>0033</phone_ext>
      <email>j.grenier@isc84.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elsa KALBACHER, MD</last_name>
      <email>ekalbacher@chu-besancon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne FLOQUET</last_name>
      <email>a.floquet@bordeaux.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Nord</name>
      <address>
        <city>Bordeaux</city>
        <zip>33300</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nadine DOHOLLOU, MD</last_name>
      <email>n.dohollou@bordeauxnord.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florence JOLY</last_name>
      <email>f.joly@baclesse.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Jean Perrin</name>
      <address>
        <city>Clermont-ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Ange MOURET, MD</last_name>
      <phone>4 73 27 80 05</phone>
      <phone_ext>0033</phone_ext>
      <email>marie-ange.mouret-reynier@cjp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Georges François Leclerc</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure FAVIER, MD</last_name>
      <email>lfavier@cgfl.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Mutualiste de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38028</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire GARNIER TIXIDRE</last_name>
      <email>c.garnier-tixidre@ghm-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Michallon - Centre Hospitalier Universitaire de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina COSTAN, MD</last_name>
      <email>ccostan@chu-grenoble.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Départemental Les Oudairies</name>
      <address>
        <city>La Roche-sur-yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tifenn L'HARIDON, MD</last_name>
      <email>tifenn.lharidon@chd-vendee.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Jean Bernard - Clinique Victor Hugo</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hugues BOURGEOIS, MD</last_name>
      <phone>2 43 47 94 94</phone>
      <phone_ext>0033</phone_ext>
      <email>h.bourgeois@cjb72.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional Universitaire de Lille - Hôpital Huriez</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe DESAUW, MD</last_name>
      <email>christophe.desauw@chru-lille.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <zip>59200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne LESOIN, MD</last_name>
      <phone>3 20 29 59 59</phone>
      <phone_ext>0033</phone_ext>
      <email>a-lesoin@o-lambret.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69373</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabelle RAY-COQUARD, PH</last_name>
      <email>isabelle.ray-coquard@lyon.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <zip>13009</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Magali PROVANSAL, MD</last_name>
      <phone>4 91 22 37 40</phone>
      <phone_ext>0033</phone_ext>
      <email>provansalm@ipc.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Mont-de-Marsan</name>
      <address>
        <city>Mont-de-marsan</city>
        <zip>40024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme DAUBA, MD</last_name>
      <email>jerome.dauba@ch-mt-marsan.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CRLC Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel FABBRO, physician</last_name>
      <phone>04 67 61 30 63</phone>
    </contact>
    <investigator>
      <last_name>Michel FABBRO, physician</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICM Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel FABBRO, MD</last_name>
      <phone>4 67 61 30 63</phone>
      <phone_ext>0033</phone_ext>
      <email>michel.fabbro@icm.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Azuréen de Cancérologie</name>
      <address>
        <city>Mougins</city>
        <zip>06250</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rémy LARGILLIER, MD</last_name>
      <email>largillier@cac-mougins.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Catherine de Sienne</name>
      <address>
        <city>Nantes</city>
        <zip>44202</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alain LORTHOLARY, MD</last_name>
      <phone>2 28 27 21 71</phone>
      <phone_ext>0033</phone_ext>
      <email>lortholary.alain@catherinedesienne.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <zip>06189</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe FOLLANA, MD</last_name>
      <phone>4 92 03 12 90</phone>
      <phone_ext>0033</phone_ext>
      <email>philippe.follana@nice.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Régional d'Orléans</name>
      <address>
        <city>Orleans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme MEUNIER, MD</last_name>
      <email>jerome.meunier@chr-orleans.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Curie - Hopital Claudius Régaud</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel RODRIGUES, MD</last_name>
      <email>manuel.rodrigues@curie.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital des Diaconesses</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric SELLE, MD</last_name>
      <email>frederic.selle@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jérôme ALEXANDRE, MD</last_name>
      <email>jerome.alexandre@cch.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Pierre LOTZ, MD</last_name>
      <phone>+33 1 56 01 60 58</phone>
      <email>jean-pierre.lotz@tnn-aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Pierre LOTZ, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Saint-Joseph</name>
      <address>
        <city>Paris</city>
        <zip>75674</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert SVERDLIN</last_name>
      <email>rsverdlin@hpsj.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75908</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre COMBE, MD</last_name>
      <email>pierre.combe@egp.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Francheville</name>
      <address>
        <city>Perigueux</city>
        <zip>20004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charkes-Briac LEVACHE, MD</last_name>
      <phone>5 53 02 13 32</phone>
      <phone_ext>0033</phone_ext>
      <email>ch.levache@oncoradio24.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-benite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoît YOU, MD</last_name>
      <email>benoit.you@chu-lyon.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Milétrie - CHU de Poitiers - Pôle Régional de Cancérologie</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadia RABAN, MD</last_name>
      <email>nadia.raban@chu-poitiers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35042</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia LEFEUVRE, MD</last_name>
      <email>c.lefeuvre@rennes.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <zip>76038</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cécile GUILLEMET, MD</last_name>
      <phone>02 32 08 22 37</phone>
      <email>cecile.guillemet@chb.unicancer.fr</email>
    </contact>
    <contact_backup>
      <last_name>Sabine GUENOT</last_name>
      <phone>02 32 08 29 10</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinique Armoricaine de Radiologie</name>
      <address>
        <city>Saint Brieuc</city>
        <zip>22015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne-Claire HARDY-BESSARD, MD</last_name>
      <phone>2 96 75 22 16</phone>
      <phone_ext>0033</phone_ext>
      <email>ac.hardy@clin-armoricaine.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital René Huguenin, Institut Curie</name>
      <address>
        <city>Saint-cloud</city>
        <zip>92210</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Coraline DUBOT</last_name>
      <email>coralline.dubot@curie.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICO Centre René Gauducheau</name>
      <address>
        <city>Saint-herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominique BERTON-RIGAUD, MD</last_name>
      <email>dominique.berton-rigaud@ico.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Radiothérapie - Clinique Sainte-Anne</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youssef TAZI, MD</last_name>
      <email>ytazi@solcrr.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Paul Strauss</name>
      <address>
        <city>Strasbourg</city>
        <zip>67065</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry PETIT, MD</last_name>
      <phone>3 88 25 24 85</phone>
      <phone_ext>0033</phone_ext>
      <email>tpetit@strasbourg.unicancer.fr;tpetit.centrepaulstrauss@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure DE COCK, MD</last_name>
      <email>laure.decock@chru-strasbourg.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Claudius Regaud</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laurence GLADIEFF, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur - ONCOSUD</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raymond DESPAX, MD</last_name>
      <email>r.despax@clinique-pasteur.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ICL Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandoeuvre-les-nancy</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Christine KAMINSKY, MD</last_name>
      <email>mc.kaminsky@nancy.unicancer.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <zip>94805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia PAUTIER, MD</last_name>
      <email>patricia.pautier@gustaveroussy.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angelika Baldauf, MD</last_name>
      <email>angelika.baldauf@klinikum-ab-alz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arthur Wischnik, MD, PhD</last_name>
      <phone>+49 821 4002331</phone>
      <email>arthur.wischnik@klinikum-augsburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hochtaunus-Kliniken</name>
      <address>
        <city>Bad Homburg</city>
        <zip>61352</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominik Denschlag, MD, PhD</last_name>
      <phone>+49 6172 14 2580</phone>
      <email>dominik.denschlag@hochtaunus-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxisklinik Krebsheilkunde für Frauen</name>
      <address>
        <city>Berlin</city>
        <zip>10367</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gülten Oskay-Özcelik, MD, PhD</last_name>
      <phone>+49 30 55 15 3825</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Berlin-Buch</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Sperfeld, MD</last_name>
      <phone>+49 30 940153300</phone>
      <email>antje.sperfeld@helios-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin (CVK)</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jalid Sehouli, MD, PhD</last_name>
      <phone>+49 30 450 564 002</phone>
      <email>jalid.sehouli@charite.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologie Bottrop</name>
      <address>
        <city>Bottrop</city>
        <zip>46236</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Hannig, MD</last_name>
      <phone>+49 2041 70 95 90</phone>
      <email>c.hannig@email.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>GYNAEKOLOGICUM Bremen</name>
      <address>
        <city>Bremen</city>
        <zip>28111</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Willibald Schröder, MD, PhD</last_name>
      <phone>+49 421 43603460</phone>
      <email>prof.schroeder@gynaekologicum-bremen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Dessau</name>
      <address>
        <city>Dessau</city>
        <zip>06847</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Voß, MD</last_name>
      <phone>+49 340 5014310</phone>
      <email>hermann.voss@klinikum-dessau.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Canzler, MD</last_name>
      <phone>+49 351 458 3508</phone>
      <email>ulrich.canzler@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Werner Meier, MD, PhD</last_name>
      <phone>+49 211 9191405</phone>
      <email>wmeier2010@gmx.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tanja Fehm, MD, PhD</last_name>
      <phone>+49 211 8117550</phone>
      <email>tanja.fehm@med.uni-duesseldorf.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Fasching, MD, PhD</last_name>
      <phone>+49 9131 8536167</phone>
      <email>peter.fasching.studien@uk-erlangen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Essen Mitte</name>
      <address>
        <city>Essen</city>
        <zip>45136</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Harter, MD</last_name>
      <phone>+49 201 17434511</phone>
      <email>p.harter@kliniken-essen-mitte.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Heubner, MD, PhD</last_name>
      <phone>+49 201 723 85647</phone>
      <email>martin.heubner@uk-essen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Esslingen</name>
      <address>
        <city>Esslingen</city>
        <zip>73730</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorsten Kühn, MD, PhD</last_name>
      <phone>+49 711 31033050</phone>
      <email>t.kuehn@klinikum-esslingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Johann Wolfgang Goethe-Universität</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed El-Balat, MD</last_name>
      <email>ahmed.el-balat@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Frankfurt Höchst</name>
      <address>
        <city>Frankfurt</city>
        <zip>65929</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Möbus, MD, PhD</last_name>
      <phone>+49 69 31062339</phone>
      <email>volker.moebus@klinikumfrankfurt.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beate Rautenberg, MD</last_name>
      <phone>+49 761 270 31260</phone>
      <email>beate.rautenberg@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Belau, MD</last_name>
      <phone>+49 3834 866462</phone>
      <email>belau@uni-greifswald.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäts-Frauenklinik Göttingen</name>
      <address>
        <city>Göttingen</city>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Günter Emons, MD, PhD</last_name>
      <phone>+49 551 39 66501</phone>
      <email>emons@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinkum Gütersloh</name>
      <address>
        <city>Gütersloh</city>
        <zip>33332</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wencke Ruhwedel, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Halle</name>
      <address>
        <city>Halle</city>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Georg Strauß, MD</last_name>
      <phone>+49 345 5571888</phone>
      <email>hans.strauss@uk-halle.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Schmalfeldt, MD, PhD</last_name>
      <phone>+49 40 741023800</phone>
      <email>b.schmalfeldt@uke.uni-hamburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Albertinen Krankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22457</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uwe Herwig, MD</last_name>
      <phone>+49 40 55886752</phone>
      <email>uwe.herwig@albertinen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gynäkologisch-Onkologische Praxis Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30177</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Joachim Lück, MD, PhD</last_name>
      <phone>+49 511 6555280</phone>
      <email>hlueck@goph.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tjoung-Won Park-Simon, MD, PhD</last_name>
      <phone>+49 511 5329454</phone>
      <email>park-simon.tjoung-won@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederik Marmé, MD, PhD</last_name>
      <phone>+49 6221 56 7884</phone>
      <email>frederik.marme@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingo Runnebaum, MD, PhD</last_name>
      <phone>+49 3641 933 063</phone>
      <email>ingo.runnebaum@med.uni-jena.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincentius Kliniken</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76135</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Tomé, MD</last_name>
      <phone>+49 721 8108 9003</phone>
      <email>oliver.tome@vincentius-ka.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Feisel-Schwickardi, MD</last_name>
      <phone>+49 561 98017547</phone>
      <email>gabriele.feisel@klinikum-kassel.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk Bauerschlag, MD, PhD</last_name>
      <phone>+49 431 597 2100</phone>
      <email>dirk.bauerschlag@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Konstanz</name>
      <address>
        <city>Konstanz</city>
        <zip>78462</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Zorr, MD</last_name>
      <phone>+49 7531 8011601</phone>
      <email>andreas.zorr@klinikum-konstanz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinikum Krefeld</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Friedrich, MD, PhD</last_name>
      <phone>+49 2151 322201</phone>
      <email>michael.friedrich@helios-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Köln</name>
      <address>
        <city>Köln</city>
        <zip>50931</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Mallmann, MD, PhD</last_name>
      <phone>+49 221 478 4940</phone>
      <email>peter.mallmann@uk-koeln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth Krankenhaus</name>
      <address>
        <city>Köln</city>
        <zip>50935</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Rein, MD, PhD</last_name>
      <phone>+49 221 4677 1301</phone>
      <email>daniel.rein@hohenlind.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Ludwigsburg</name>
      <address>
        <city>Ludwigsburg</city>
        <zip>71640</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claudia Hänle, MD</last_name>
      <email>claudia.haenle@kliniken-lb.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lars Hanker, MD, PhD</last_name>
      <phone>Lars.Hanker@uksh.de</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg</name>
      <address>
        <city>Marburg</city>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matthias Kalder, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johannes Wesling Klinikum</name>
      <address>
        <city>Minden</city>
        <zip>32429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Heinrich Woeltjen, MD</last_name>
      <email>hans-heinrich.woeltjen@muehlenkreiskliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Burges, MD</last_name>
      <phone>+49 89 70950</phone>
      <email>alexander.burges@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum rechts der Isar</name>
      <address>
        <city>München</city>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Schnelzer, MD, PhD</last_name>
      <email>andreas.schnelzer@lrz.tum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Münster</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Witteler, MD</last_name>
      <phone>+49 251 8348236</phone>
      <email>ralf.witteler@ukmuenster.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken des Landkreises Neumarkt</name>
      <address>
        <city>Neumarkt</city>
        <zip>92318</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heinz Scholz, MD, PhD</last_name>
      <phone>+49 9181 420 3748</phone>
      <email>heinz.scholz@klinikum.neumarkt.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sana Klinikum Offenbach</name>
      <address>
        <city>Offenbach</city>
        <zip>63069</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jackisch, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ortenau Klinikum</name>
      <address>
        <city>Offenburg</city>
        <zip>77654</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Frank, MD</last_name>
      <phone>+49 781 4723503</phone>
      <email>matthias.frank@og.ortenau-klinikum.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologie Ravensburg</name>
      <address>
        <city>Ravensburg</city>
        <zip>88212</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Gropp-Meier, MD</last_name>
      <phone>+49 751 872447</phone>
      <email>martina.gropp-meier@oberschwabenklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Buchholz, MD, PhD</last_name>
      <email>sbuchholz@caritasstjosef.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum am Steinenberg</name>
      <address>
        <city>Reutlingen</city>
        <zip>72764</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peter Krieger, MD</last_name>
      <phone>+49 7121 2003980</phone>
      <email>krieger_p@klin-rt.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ROMed Klinikum Rosenheim</name>
      <address>
        <city>Rosenheim</city>
        <zip>83022</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas Beck, MD, PhD</last_name>
      <email>thomas.beck@ro-med.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Südstadt</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Max Dieterich, MD</last_name>
      <phone>+49 381 44014600</phone>
      <email>max.dieterich@kliniksued-rostock.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Robert-Bosch-Krankenhaus</name>
      <address>
        <city>Stuttgart</city>
        <zip>70376</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annette Steckkönig, MD</last_name>
      <email>annette.steckkoenig@rbk.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäts-Frauenklinik Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva-Maria Grischke, MD, PhD</last_name>
      <phone>+49 7121 2003980</phone>
      <email>eva-maria.grischke@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikloaus de Gregorio, MD</last_name>
      <email>niko_g@gmx.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HELIOS Dr. Horst Schmidt Kliniken</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tanja Neunhöffer, MD</last_name>
      <email>tanja.neunhoeffer@helios-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marien Hospital Witten</name>
      <address>
        <city>Witten</city>
        <zip>58452</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörn Treustedt, MD</last_name>
      <email>joern.treustedt@elisabethgruppe.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>amO Wolfsburg</name>
      <address>
        <city>Wolfsburg</city>
        <zip>38440</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Clemens Liebrich, MD</last_name>
      <phone>+49 5361 803813</phone>
      <email>clemens.liebrich@klinikum.wolfsburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Worms</name>
      <address>
        <city>Worms</city>
        <zip>67550</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Kögel, MD</last_name>
      <phone>+49 6241 5013503</phone>
      <email>matthias.koegel@klinikum-worms.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Achim Wöckel, MD, PhD</last_name>
      <phone>+49 931 201 25 621</phone>
      <email>woeckel_a@ukw.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centro Riferimento Oncologico</name>
      <address>
        <city>Aviano</city>
        <zip>33081</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roberto Sorio, MD</last_name>
      <phone>0434/659499</phone>
      <email>rsorio@cro.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico S.Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudio Zamagni, MD</last_name>
      <phone>0516364548</phone>
      <email>claudio.zamagni@aosp.bo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spedali Civili-Università di Brescia</name>
      <address>
        <city>Brescia</city>
        <zip>25120</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Germana Tognon, MD</last_name>
      <phone>030-3996674</phone>
      <email>germanatognon@alice.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Senatore Antonio Perrino</name>
      <address>
        <city>Brindisi</city>
        <zip>72100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saverio Cinieri, MD</last_name>
      <phone>0831537218</phone>
      <email>saverio.cinieri@ieo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>EO Ospedali Galliera</name>
      <address>
        <city>Genova</city>
        <zip>16128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Decensi, MD</last_name>
      <phone>0105634521</phone>
      <email>andrea.decensi@galliera.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Luca</name>
      <address>
        <city>Lucca</city>
        <zip>55100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Editta Baldini, MD</last_name>
      <phone>058 / 3449545</phone>
      <email>e.baldini@usl2.toscana.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Tumori</name>
      <address>
        <city>Milano</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ketta Lorusso, MD</last_name>
      <phone>02/23902815</phone>
      <email>Domenica.Lorusso@istitutotumori.mi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Europeo di Oncologia</name>
      <address>
        <city>Milano</city>
        <zip>20141</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicoletta Colombo, MD</last_name>
      <phone>0257489935</phone>
      <email>nicoletta.colombo@ieo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Nazionale Tumori - IRCCS Pascale</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sangro Pignata, MD</last_name>
      <phone>081/5903637</phone>
      <email>s.pignata@istitutotumori.na.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto</name>
      <address>
        <city>Padova</city>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Ornella Nicoletto, MD</last_name>
      <phone>049/8215931-5927</phone>
      <email>mariaorn@libero.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Maria della Misericordia</name>
      <address>
        <city>Perugia</city>
        <zip>06122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Maria Mosconi, MD</last_name>
      <phone>075-5784186</phone>
      <email>annamaria.mosconi@alice.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Chiara</name>
      <address>
        <city>Pisa</city>
        <zip>56124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angiolo Gadducci, MD</last_name>
      <phone>050992609-050992603</phone>
      <email>a.gadducci@med.unipi.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AO ASL 4 - Ospedale di Prato</name>
      <address>
        <city>Prato</city>
        <zip>59100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elena Zafarana, MD</last_name>
      <phone>0574/434766-246</phone>
      <email>ezafarana@usl4.toscana.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arcispedale S. M. Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alessandra Bologna, MD</last_name>
      <phone>0522-296858</phone>
      <email>Alessandra.Bologna@asmn.re.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Regina Elena</name>
      <address>
        <city>Roma</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Antonella Savarese, MD</last_name>
      <phone>06/52666773</phone>
      <email>savarese@ifo.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I La Sapienza</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierluigi Benedetti Panici, MD</last_name>
      <phone>06-4940550</phone>
      <email>pierluigi.benedettipanici@uniroma1.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Gemelli Università Cattolica del Sacro Cuore</name>
      <address>
        <city>Roma</city>
        <zip>00168</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giovanni Scambia</last_name>
      <phone>0630158545</phone>
      <email>clinicaltrials@rm.unicatt.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Anna</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Paolo Zola, MD</last_name>
      <phone>0113131523</phone>
      <email>Paolo.zola@unito.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Mauriziano</name>
      <address>
        <city>Torino</city>
        <zip>10128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anna Maria Ferrero, MD</last_name>
      <phone>3358001042</phone>
      <email>a.ferrero@katamail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Santa Chiara</name>
      <address>
        <city>Trento</city>
        <zip>38100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Viviana Murgia, MD</last_name>
      <phone>0461902478</phone>
      <email>alessia.caldara@apss.tn.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ehime University Hospital</name>
      <address>
        <city>Ehime</city>
        <zip>791-0204</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Takashi MATSUMOTO</last_name>
      <phone>+81-89-960-5379</phone>
      <email>matsugen@m.ehime-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hyogo Cancer Center</name>
      <address>
        <city>Hyogo</city>
        <zip>673-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shoji NAGAO, MD</last_name>
      <phone>+81-78-929-1151</phone>
      <email>nagao@hp.pref.hyogo.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Tsukuba Hospital</name>
      <address>
        <city>Ibaragi</city>
        <zip>305-0005</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Toyomi SATO, MD</last_name>
      <phone>+81-29-853-3900</phone>
      <email>toyomi-s@md.tsukuba.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kagoshima University Medical And Dental Hospital</name>
      <address>
        <city>Kagoshima</city>
        <zip>890-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroaki KOBAYASHI, MD</last_name>
      <phone>+81-99-275-5423</phone>
      <email>hirokoba@m2.kufm.kagoshima-u.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saitama Medical University International Medical Center</name>
      <address>
        <city>Saitama</city>
        <zip>350-1298</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroyuki YOSHIDA, MD</last_name>
      <phone>+81-42-984-4472</phone>
      <email>hiro_y@saitama-med.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Jichi Medical University Hospital</name>
      <address>
        <city>Tochigi</city>
        <zip>329-0498</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hiroyuki FUJIWARA, MD</last_name>
      <phone>+81-285-58-7376</phone>
      <email>fujiwara@jichi.ac.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Cancer Center Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>104-0045</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kenji TAMURA, MD</last_name>
      <phone>+81-3-3542-2511</phone>
      <email>ketamura@ncc.go.jp</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Princesse Grace</name>
      <address>
        <city>Monaco</city>
        <zip>98000</zip>
        <country>Monaco</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Georges Garnier, MD</last_name>
      <phone>00 377 97 98 95 91</phone>
      <email>ggarnier@chpg.mc</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. U. Fundación Alcorcón</name>
      <address>
        <city>Alcorcón</city>
        <zip>28922</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susana Hernando Polo, MD</last_name>
      <phone>916219256</phone>
      <email>shernando@fhalcorcon.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>8026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristina Martín, MD</last_name>
      <phone>93 553 71 18</phone>
      <email>CMartinL@santpau.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>C.S. Parc Taulí</name>
      <address>
        <city>Barcelona</city>
        <zip>8208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yolanda García, MD</last_name>
      <phone>93 724 00 84</phone>
      <email>ygarcia@tauli.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. U. Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Jesús Rubio, MD</last_name>
      <phone>957011464 (511464)</phone>
      <email>mjruper@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U. Arnau de Vilanova</name>
      <address>
        <city>Lleida</city>
        <zip>25198</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eugenia Ortega, MD</last_name>
      <phone>973705351</phone>
      <email>eortegai@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28033</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio González Martín</last_name>
      <phone>91 787 86 00 Ext 2883</phone>
      <email>agonzalezm@seom.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. U. Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Maria Guerra Alía, MD</last_name>
      <phone>913368000</phone>
      <email>eva_m_guerra@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. U. 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cesar mendiola Fernández</last_name>
      <phone>91 390 86 26</phone>
      <email>cmontalban@h12o.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Navarra</city>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nuria Lainez Milagro, MD</last_name>
      <phone>848.42.25.76</phone>
      <email>nuria.lainez.milagro@cfnavarra.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H.U. Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <zip>33011</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Palacio, MD</last_name>
      <phone>985 10 61 00 ext. 36281</phone>
      <email>isabel.palacio@sespa.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. General Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Caballero, MD</last_name>
      <phone>963187527</phone>
      <email>caballero_cri@gva.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. U. P. La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ana Santaballa, MD</last_name>
      <phone>961244000</phone>
      <email>santaballa_ana@gva.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de Oncología</name>
      <address>
        <city>València</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ignacio Romero, MD</last_name>
      <phone>96 110 4606</phone>
      <email>nachete54@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>H. U. Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Herrero, MS</last_name>
      <phone>976765500 ext. 3825</phone>
      <email>herreroa@yahoo.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Per ROSENBERG, MD</last_name>
      <phone>0046101032017</phone>
      <email>per.rosenberg@regionostergotland.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Japan</country>
    <country>Monaco</country>
    <country>Spain</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 23, 2015</study_first_posted>
  <last_update_submitted>September 13, 2016</last_update_submitted>
  <last_update_submitted_qc>September 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Advanced FIGO IIIB</keyword>
  <keyword>IV high grade serious ovarian cancer</keyword>
  <keyword>endometrioid ovarian cancer</keyword>
  <keyword>standard first-line treatment</keyword>
  <keyword>platinum-taxane chemotherapy</keyword>
  <keyword>bevacizumab</keyword>
  <keyword>olaparib</keyword>
  <keyword>placebo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olaparib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

